UBS Maintains Neutral Rating for Chemours: Here's What You Need To Know

UBS Maintains Neutral Rating for Chemours: Here's What You Need To Know

UBS has decided to maintain its Neutral rating of Chemours CC and raise its price target from $35.00 to $37.00.

Shares of Chemours are trading up 3.55% over the last 24 hours, at $36.14 per share.

A move to $37.00 would account for a 2.38% increase from the current share price.

About Chemours

The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets. The company's operating segments include Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment, a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, and protection in a variety of applications. Geographically, it derives a majority of revenue from North America.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-AAR-UPDATEAnalyst Ratings